SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-038685
Filing Date
2018-07-17
Accepted
2018-07-17 16:35:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tv498674_s3.htm S-3 156329
2 EXHIBIT 5 tv498674_ex5.htm EX-5 8431
3 EXHIBIT 23.1 tv498674_ex23-1.htm EX-23.1 2665
4 GRAPHIC casi_logo.jpg GRAPHIC 13735
5 GRAPHIC ap_logo.jpg GRAPHIC 11094
6 GRAPHIC ap_footer.jpg GRAPHIC 5057
  Complete submission text file 0001144204-18-038685.txt   210089
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-226206 | Film No.: 18956835
SIC: 2836 Biological Products, (No Diagnostic Substances)